×

Member Login

Home / Categories / By country / America / North America / Canada / HCP - Canada

Premium Content

Viewing ads is reserved for Premium and Trial members.

You are currently browsing the archive with a Free Basic Account.


Download available for Premium Members

Timoptic and Istalol - the morning

Aqueous humor production is highest in the morning

Classic beta blocker adjunctive therapy for the right patient at the right time

The concomitant use of two topical beta-adrenergic blocking agents is not recommended

Indications and Usage

ISTALOL (timolol maleate ophthalmic solution) is a non-selective beta-adrenergic receptor blocking agent indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Preservative-free TIMOPTIC (timolol maleate ophthalmic solution) in OCUDOSE (dispenser) is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. It may be used when a patient is sensitive to the preservative in TIMOPTIC (timolol maleate ophthalmic solution), benzalkonium chloride, or when use of a preservative-free topical medication is advisable.

For the patients who need incremental IOP reduction in a preservative free form

TIMOPTIC in OCUDOSE

For the patients who need incremental IOP reduction in a once a day form

Istalol
(timolol maleate ophthalmic solution)0.5%

BAUSCH and LOMB


Brand: Timoptic and Istalol
Country/Market: Canada, North America
Target: Healthcare Professional (HCP)
Size/duration: Single-page
Publication/Aired:
Review Of Ophthalmology - December 2014


See more Timoptic and Istalol ads here

About  Subscriptions  Contact us  YouTube  LinkedIn  Bluesky Email Newsletter